Dr. Mori is Director of R&D at NATiAS since 2021 and a visiting professor at Kobe University Graduate School of Science, Technology and Innovation. Prior to NATiAS, he started his carrier as medicinal chemist at Novartis and GSK, and moved to Pfizer as a director of chemistry department at the Nagoya site in Japan. After nearly 20 years’ experience in pharmaceutical industry, he then moved to Kobe University as a professor working on drug discovery projects. He received his M.S. from Kyoto University and Ph.D. from U.C. Berkeley. He was a postdoc with Prof. Rick Danheiser at Massachusetts Institute of Technology and a visiting scholar with Prof. Christopher Walsh at Harvard Medical School.